leisure time -WSS

leisure time

author：leisure time 2025-09-27 10:04:10 - browse：2

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Sweden knocks USA out of World Cup in penalty kicks

WSS

Restaurant meals are packed with calories, and we still keep eating them

Pennsylvania man bitten on the head by bear during attack in his garage

'Brian's Song' at 50 still offers lessons about cancer for today

'Brian's Song' at 50 still offers lessons about cancer for today

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Kansas bar where gunfire wounded 9 last month closes permanently

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Cancer drug shortages should be causing more outrage

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

23andMe had bad news about my health. I wish a person had delivered it

Failure, not just success, should guide future doctors

The cancer drug shortage isn’t new — and neither are the solutions

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Hollywood unions extend contract negotiations for actors

Tuberculosis patients need more than just free medication

Trump demands the U.S. pay no more for drugs than other countries … again

Feed a cold, starve a fever? Here’s what science says

leisure time

Election results set back Medicaid expansion plans

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

'Brian's Song' at 50 still offers lessons about cancer for today

Paxlovid rebound happens. Why and to whom are still a mystery

Sweden knocks USA out of World Cup in penalty kicks

Tuberculosis patients need more than just free medication

knowledge

entertainment

leisure time

hotspot